Menu

EMA approved a record 28 biosimilars in 2024

Reports/ | Posted 28/03/2025 comments 0
05 AA011027

In January 2025, the European Medicines Agency (EMA) released a report of its key figures for the authorization of new and biosimilar medicines in 2024. Highlights include groundbreaking treatments...

More >
FORO LATINOAMERICANO DE ESTA SEMANA
01 AA007239
FDA proposal to remove biosimilar interchangeability status in FY25
Posted 12/06/2024

In a major shift in regulatory policy, the US Food and Drug Administration (FDA)&n...

Pay for Delay DrugsMoneyGeneric V13F21
Disruption in the US adalimumab market
Posted 05/06/2024

In April 2024, Evernorth Health Services in the US announced that a biosimila...

TNFa Crystal Structure V18K17
Topline results from clinical development programme for candidate biosimilar AVT05 golimumab
Posted 23/07/2024

In April and June 2024, Icelandic biosimilar company Alvotech announced promising resul...

Home/Non‐Biological Complex Drugs
Liposome V15L11

FDA issues final guidance on liposome drug products

Posted 27/04/2018 comments 0

On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft guidance...

More >